Q2 2026 Behavioral Health M&A Report
- Aug 6
- 7 min read
Updated: Aug 12
Behavioral Health M&A
By Kevin Taggart, CM&AP, Managing Partner, Mertz Taggart
Published August 2026. Transaction data reflects deals closed between April 1 and June 30, 2026, as tracked by Mertz Taggart.
At a Glance Behavioral health M&A slowed in Q2 2026. A total of 27 transactions closed during the quarter — 21 traditional M&A deals and 6 growth deals — making it the lightest quarter for closed traditional volume in the Mertz Taggart data set going back to 2022. Mental health led all sub-sectors with 14 closed deals, followed by autism and I/DD with 6 and addiction treatment with 2. Two new private equity platforms formed, nonprofit and health-system combinations accounted for roughly a third of closed traditional volume, and several of the quarter's largest transactions were announced rather than closed. |
A total of 27 closed transactions — 21 traditional M&A deals and 6 growth deals — were reported in Q2 2026. Traditional M&A volume declined from 34 closed deals in Q1 2026 and 29 in Q2 2025, making it the lightest quarter for closed behavioral health M&A in our data set going back to 2022. The six growth deals carried a combined disc`losed value of approximately $183.8 million across the six rounds with disclosed terms.
"Volume was down, but the composition of the quarter is more interesting than the count. Two new private equity platforms formed, one of the largest nonprofit combinations we've seen in years closed, and the sponsor-backed strategics that have driven this market for three years kept buying — just in smaller bites. What we're not seeing is the mid-size auction. Buyers are there; sellers of scale largely sat out the quarter." — Mertz Taggart Managing Partner Kevin Taggart said.
Why nonprofit combinations stood out
Nonprofit and health-system combinations were unusually prominent, accounting for roughly a third of closed traditional volume. Several were driven by Medicaid economics, with acquired organizations citing scale as the path to absorbing reimbursement shortfalls. It is one quarter, not a trend, but worth watching as state budgets tighten.
"Anyone underwriting behavioral health right now is underwriting Medicaid more cautiously than in years past, but we expect this to pass as things eventually quiet down in DC. Buyers with capital are being deliberate — paying up for clean, in-network, growing businesses and being more diligent on everything else. For an owner, that spread is the whole story." — Taggart said.
Addiction Treatment M&A
Two addiction treatment deals closed in Q2 2026, down from 6 in Q1 2026 and 7 in Q2 2025, and the lowest quarterly total in our data set. Substance use disorder deal flow has trailed its 2022 pace for several consecutive quarters as platforms work through integration, payer contracting and, in a few cases, balance sheet repair.
MKH Capital Partners forms a new platform with Haven Health Management
The most significant addiction treatment transaction of the quarter was MKH Capital Partners' platform acquisition of Haven Health Management, a Palm Springs, Florida-based operator of 22 Joint Commission-accredited mental health and substance use treatment locations across nine states and Puerto Rico with nearly 2,000 employees. Brands include Indiana Center for Recovery, The Haven Detox and The Recovery Team. Terms were undisclosed but described as nine figures. MKH concurrently acquired United Billing Solutions to support in-network billing across Haven's brands, and named Brian Thorn chief executive officer.
Advantage Behavioral Health highlights
A sizable behavioral health transaction was also announced (not closed) during the quarter: Advantage Behavioral Health agreed to be acquired by QCF/I, Inc. in a transaction financed through a planned $610 million non-rated municipal bond issuance, although the deal had not closed as of quarter-end. Clearview Capital, Advantage’s founders and management were expected to receive approximately $415 million at closing, with the potential for an additional $100 million tied to performance milestones. We classified the transaction within mental health because mental health is Advantage’s primary line of business, although the company also provides substance use disorder services. The announcement is another positive signal that investors remain interested in scaled SUD platforms.
Also in the quarter, Abacus Investments-backed Recover Now closed its merger with Widespread Wellness, a Tennessee-based outpatient provider.
“Two closings is a low number, and I don’t want to over-read it. SUD is where the gap between good assets and everything else is widest right now. Platforms are still looking, but they’re selective on payer mix and length of stay, and some are still cleaning up what they bought in 2021 and 2022. For a quality operator, there’s very little competing supply. It was also encouraging to see a transaction like Haven close and Advantage Behavioral Health get announced, largely because of the scale of both businesses,” Taggart said.
Mental Health M&A
Fourteen mental health deals closed in Q2 2026, down from 18 in Q1 2026 and 20 in Q2 2025. The sub-sector continues to account for the majority of behavioral health transaction volume, with activity split between technology-enabled platforms consolidating and a steady base of outpatient psychiatry and community provider combinations.
The quarter's largest mental health transactions
PsychPlus acquired Koa Health, a multinational digital mental health company, in a combination the buyer describes as the largest technology-enabled mental health platform globally, serving more than six million patients across the U.S., Europe, Australia and Asia-Pacific. PsychPlus operates more than 200 U.S. locations; Koa founder Dr. Oliver Harrison becomes president of PsychPlus.
Spring Health closed its acquisition of Alma, the mental health provider marketplace, materially expanding Spring Health's in-network provider supply. The deal was announced in Q1 and closed May 1st.
WPS Health Insurance acquired Mavida Health, a women's mental health platform — one of the quarter's few payer-side acquisitions of a virtual provider.
Other closed mental health transactions:
Thurston Group-backed Arc Health acquired North Carolina Mental Health & Psychiatry Group.
Hillandale Advisors-backed Sidekick Therapy Partners acquired Word of Mouth Clinical Associates, a Tennessee pediatric therapy practice.
Curio Digital Therapeutics acquired the Nora Mental Health franchise system, adding a national outpatient footprint to its digital platform.
Unyte Health acquired Vital Links and Vital Sounds, the developers of Therapeutic Listening.
Sweetser acquired Common Ties Mental Health, and Keystone Human Services merged with Mikayla's Voice — both nonprofit combinations.
UConn Health assumed operation of the state-run Albert J. Solnit Children's Center in Middletown, Connecticut; Neosho Memorial Regional Medical Center acquired Kansas-based Ashley Clinic; and Xpress Wellness Urgent Care acquired Wichita's Midwest Counseling Services.
Mental health deals highlights
Several larger mental health transactions were announced but had not closed at quarter end. Clearview Capital agreed to exit Advantage Behavioral Health, a New Jersey-based operator of more than 30 mental health and sober-living facilities in eight states, to nonprofit QCF/I, Inc., financed by a planned $610 million non-rated municipal bond issuance. Clearview and ABH's founders and management are expected to receive roughly $415 million at closing, with up to $100 million more tied to milestones. ABH is projected to generate approximately $170 million of revenue and $78 million of EBITDA this year.
Mental health growth capital in Q2 2026
HPS Investment Partners agreed to take majority ownership of Discovery Behavioral Health in exchange for a substantial debt reduction, subject to regulatory approval. Universal Health Services' $835 million acquisition of Talkspace was approved by shareholders May 30 and is expected to close in Q3 2026.
On the growth side, mental health accounted for all six of the quarter's rounds. Click Therapeutics raised $50 million in a Series D from Boehringer Ingelheim to commercialize CT-155, a prescription digital therapeutic for schizophrenia symptoms. Tava Health raised a $40 million Series C led by Centana Growth Partners; Instride Health raised $30 million from Echo Health Ventures; Klinic raised $24 million; Zocalo Health raised $22.8 million from EO Ventures; and Vanna Health raised $17 million from Health Velocity Capital.
Autism and Intellectual/Developmental Disabilities M&A
Six autism and I/DD deals closed in Q2 2026, down from 10 in Q1 2026 and roughly in line with the 7 closed in Q2 2025. New platform formation and nonprofit consolidation drove the quarter.
Merakey and I Am Boundless: the quarter's largest behavioral health transaction
The largest transaction of the quarter in any behavioral health sub-sector was Merakey's acquisition of I Am Boundless, an Ohio nonprofit serving people with intellectual and developmental disabilities and behavioral health needs. Merakey, a Pennsylvania-based nonprofit operating in 12 states, and Boundless will together generate up to $1 billion in annual revenue, with Boundless keeping its name and leadership. Boundless had grown revenue from $20 million to an expected $200 million through five acquisitions in seven years, and its CEO pointed to Medicaid shortfalls as the reason it sought a larger partner.
Cathay Capital launches Ascendia Autism Care
Cathay Capital launched Ascendia Autism Care, a new applied behavior analysis platform built around a founding affiliate operating 20 centers across eight states with more than 400 clinicians. Ascendia focuses on early intervention for children ages two to six and plans to grow through de novo expansion and additional clinical partnerships.
Additional Q2 autism and I/DD transactions:
Gryphon Investors-backed LEARN Behavioral acquired Little Leaves Behavioral Services from FullBloom.
Frontline Healthcare Partners-backed JoyBridge Kids acquired A Bridge to Achievement, its first step into adult services.
Doma acquired MPA Services, an Ohio I/DD provider.
The founders of North Arrow ABA in Michigan converted the practice to 100% employee ownership.
"ABA and I/DD are still where the most consistent buyer interest is, and Cathay's launch is a good example — a firm entering around a single high-quality founding group rather than buying a built rollup. The other story is the nonprofit side moving. Merakey and I am Boundless exists because the Medicaid math doesn't work at smaller scale according to I am Boundless, and I expect more of those combinations over the next 18 months." — Taggart said.
If you are interested in downloading the PDF version of the Q2 2026 Behavioral Health M&A Report, click the download link below:
Comments